Article Text

PDF
Relapsing encephalopathy in a patient with α-methylacyl-CoA racemase deficiency
  1. S A Thompson1,
  2. J Calvin2,
  3. S Hogg2,
  4. S Ferdinandusse3,
  5. R J A Wanders3,
  6. R A Barker1
  1. 1
    Department of Neurology, Addenbrooke’s Hospital, Cambridge, UK
  2. 2
    Biochemical Genetics Unit, Addenbrooke’s Hospital, Cambridge, UK
  3. 3
    Laboratory Genetic Metabolic Diseases, Academic Medical Centre, Amsterdam, The Netherlands
  1. Dr R A Barker, Centre for Brain Repair, Forvie Site, Robinson Way, Cambridge, CB2 2PY, UK; rab46{at}cam.ac.uk

Abstract

α-Methylacyl-CoA racemase (AMACR) deficiency is a rare disorder of fatty acid metabolism which has recently been described in three adult cases. We have identified a further patient with clinical features of a relapsing encephalopathy, seizures and cognitive decline over a 40 year period. Biochemical studies revealed grossly elevated plasma pristanic acid levels, and a deficiency of AMACR in skin fibroblasts. Sequence analysis of AMACR cDNA identified a homozygous point mutation (c154T>C). This case adds to the phenotypic variation seen in this peroxisomal disorder and highlights the importance of screening for plasma pristanic acid levels in patients with unexplained relapsing encephalopathies.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.